Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus

Document Viewer

Share this page:

Title

Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus

Subject

Description

From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States.

Date Last Updated (Year-Month-Day)

2016-08-01

Citation

Wong, K. K., R. T. Davey, Jr., A. L. Hewlett, C. S. Kraft, A. K. Mehta, M. J. Mulligan, A. Beck, W. Dorman, C. J. Kratochvil, L. Lai, T. N. Palmore, S. Rogers, P. W. Smith, A. F. Suffredini, M. Wolcott, U. Stroher and T. M. Uyeki (2016). "Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus." Clin Infect Dis 63(3): 376-379.

Abstract

From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.

Accessibility

free online - Pubmed Central